This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Feinberg WM, Blackshear JL, Laupacis A et al (1995) Prevalence, age distribution, and gender of patients with atrial fibrillation: analysis and implications. Arch Intern Med 155:469–473
Benjamin EJ, Levy D, Vaziri SM et al (1994) Independent risk factors for atrial fibrillation in a population-based cohort: the Framingham Heart Study. JAMA 271:840–844
Kannel WB, Wolf PA, Benjamin EJ et al (1998) Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol 82:2N–9N
Krahn AD, Manfreda J, Tate RB et al (1995) The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med 98:476–484
Benjamin EJ, Wolf PA, D’Agostino RB et al (1998) Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 98:946–952
Lüeritz B, Jung W (2000) Quality of life in patients with atrial fibrillation. Arch Intern Med 160:1749–1757
Jung W, Lüeritz B (1998) Quality of life in patients with atrial fibrillation. J Cardiovasc Electrophysiol 9(suppl 8):S177–S186
Crijns HJGM, Van Gelder IC, Tieleman RG et al (1997) Why is atrial fibrillation bad for you? In: Murgatroyd FD, Camm AJ (eds) Nonpharmacological management of atrial fibrillation. Futura, Armonk, NY, pp 3–13
Schumacher B, Lüeritz B (1998) Rate issues in atrial fibrillation: consequences of tachycardia and therapy for rate control. Am J Cardiol 82:29N–36N
Lönerholm S, Blomstro P, Nilsson L et al (2000) Effects of the maze operation on health-related quality of life in patients with atrial fibrillation. Circulation 101:2607–2611
Wellens JJW, Lau CP, Lüeritz B et al for the METRIX Investigators (1998) Atrioverter: an implantable device for the treatment of atrial fibrillation. Circulation 98:1651–1656
Lüeritz B, Jung W (2000) Quality of life in atrial fibrillation. J Intervent Card Electrophysiol 4:201–209
Savelieva I, Paquette M, Dorian P (2001) Quality of life in patients with silent atrial fibrillation. Heart 85:216–217
Wyse DG (2000) The AFFIRM trial: Main trial and substudies — what can we expect? J Interv Card Electrophysiol 4:171–176
Heinz G, Siostrzonek P, Kreiner G et al (1992) Improvement in left ventricular systolic function after successful radiofrequency His bundle ablation for drug refractory, chronic atrial fibrillation and recurrent atrial flutter. Am J Cardiol 69:489–492
Twidale N, Sutton K, Bartlett L et al (1993) Effects on cardiac performance of atrioventricular node catheter ablation using radiofrequency current for drug-refractory atrial arrhythmias. Pacing Clin Electrophysiol 16:1275–1284
Rodriguez LM, Smeets JL, Xie B et al (1993) Improvement in left ventricular function by ablation of atrioventricular nodal conduction in selected patients with lone atrial fibrillation. Am J Cardiol 72:1137–1141
Brignole M, Gionfranchi L, Menozzi C et al (1994) Influence of atrioventricular junction radiofrequency ablation patients with chronic atrial fibrillation and flutter on quality of life and cardiac performance. Am J Cardiol 74:242–246
Edner M, Caidahl K, Bergfeldt L et al (1995) Prospective study of left ventricular function after radiofrequency ablation of atrioventricular junction in patients with atrial fibrillation. Br Heart J 74:261–267
Fitzpatrick AP, Kourouyan HD, Siu A et al (1996) Quality of life and outcomes after radiofrequency His-bundle catheter ablation and permanent pacemaker implantation: impact of treatment in paroxysmal and established atrial fibrillation. Am Heart J 131:499–507
Natale A, Zimerman L, Tomassoni G et al (1996) Impact on ventricular function and quality of life of transcatheter ablation of the atrioventricular junction in chronic atrial fibrillation with a normal ventricular response. Am J Cardiol 78:1431–1433
Steinbeck G (1996) Drug therapy of atrial fibrillation: control of heart rate versus establishing sinus rhythm (in German). Z Kardiol 85(Suppl 6):69–74
Bathina MN, Mickelsen S, Brooks C et al (1998) Radiofrequency catheter ablation versus medical therapy for initial treatment of supraventricular tachycardia and its impact on quality of life and healthcare costs. Am J Cardiol 82:589–593
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer-Verlag Italia
About this chapter
Cite this chapter
Lüeritz, B. (2006). Atrial Fibrillation: What Is the Impact of the Different Therapies on Quality of Life?. In: Raviele, A. (eds) Cardiac Arrhythmias 2005. Springer, Milano. https://doi.org/10.1007/88-470-0371-7_10
Download citation
DOI: https://doi.org/10.1007/88-470-0371-7_10
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-0370-5
Online ISBN: 978-88-470-0371-2
eBook Packages: MedicineMedicine (R0)